VERRICA PHARMACEUTICALS INC (VRCA) Forecast, Price Target & Analyst Ratings

NASDAQ:VRCA • US92511W2070

Current stock price

6.38 USD
+0.06 (+0.95%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for VERRICA PHARMACEUTICALS INC (VRCA).

Forecast Snapshot

Consensus Price Target

Price Target
$16.83
+ 163.79% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 12, 2026
Period
Q1 / 2026
EPS Estimate
-$0.46
Revenue Estimate
4.61M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
81.82%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$16.83
Upside
+ 163.79%
From current price of $6.38 to mean target of $16.83, Based on 11 analyst forecasts
Low
$10.10
Median
$18.36
High
$21.00

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

11 Wall Street analysts provided a forecast for the next 12 months for VRCA. The average price target is 16.83 USD. This implies a price increase of 163.79% is expected in the next year compared to the current price of 6.38.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

VRCA Current Analyst RatingVRCA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5

Analyst Ratings History

VRCA Historical Analyst RatingsVRCA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
81.82%
VRCA was analyzed by 11 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about VRCA.
In the previous month the buy percentage consensus was at a similar level.
VRCA was analyzed by 11 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-12-18Brookline CapitalUpgrade Hold -> Buy
2025-05-14NeedhamReiterate Hold -> Hold
2025-04-09NeedhamReiterate Hold -> Hold
2025-04-08HC Wainwright & Co.Reiterate Neutral -> Neutral
2025-03-12NeedhamReiterate Hold -> Hold
2024-12-20NeedhamReiterate Hold -> Hold
2024-11-06HC Wainwright & Co.Downgrade Buy -> Neutral
2024-11-05NeedhamReiterate Hold
2024-11-05RBC CapitalDowngrade Outperform -> Sector Perform
2024-10-21TD CowenMaintains Buy -> Buy
2024-10-04RBC CapitalMaintains Outperform -> Outperform
2024-10-03NeedhamDowngrade Buy -> Hold
2024-10-02Brookline CapitalDowngrade Buy -> Hold
2024-08-15NeedhamMaintains Buy -> Buy
2024-08-15RBC CapitalMaintains Outperform -> Outperform
2024-05-16NeedhamReiterate Buy -> Buy
2024-05-14NeedhamMaintains Buy -> Buy
2024-05-14HC Wainwright & Co.Maintains Buy -> Buy
2024-04-10NeedhamReiterate Buy -> Buy
2024-03-01NeedhamReiterate Buy -> Buy
2024-03-01HC Wainwright & Co.Maintains Buy -> Buy
2023-12-15JefferiesReiterate Buy -> Buy
2023-11-10NeedhamMaintains Buy -> Buy
2023-10-12HC Wainwright & Co.Reiterate Buy -> Buy
2023-08-23NeedhamReiterate Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 12, 2026
Period
Q1 / 2026
EPS Estimate
-$0.46
Revenue Estimate
4.61M
Revenue Q2Q
34.72%
EPS Q2Q
54.47%
Number of Analysts
7

Next Earnings Revisions

Revenue (1 Month)
-7.76%
Revenue (3 Months)
-19.29%
EPS (1 Month)
4.29%
EPS (3 Months)
10.73%

Next Earnings Summary

VRCA is expected to report earnings on 5/12/2026. The consensus EPS estimate for the next earnings is -0.46 USD and the consensus revenue estimate is 4.61M USD.
The next earnings revenue estimate has been revised downward by 19.29% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
VRCA revenue by date.VRCA revenue by date.
5.124M
-43.26%		7.566M
47.66%		35.577M
370.22%		25.327M
-28.81%		49.246M
94.44%		88.97M
80.66%		172.79M
94.21%		198.39M
14.82%		229.76M
15.81%		243.27M
5.88%		254.44M
4.59%
EBITDA
YoY % growth
VRCA ebitda by date.VRCA ebitda by date.
-62.672M
-200.73%		-64.875M
-3.52%		-11.454M
82.34%		-25.092M
-119.07%		N/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
VRCA ebit by date.VRCA ebit by date.
-63.222M
-196.96%		-65.836M
-4.13%		-11.939M
81.87%		-25.161M
-110.75%		-10.963M
56.43%		18.819M
271.66%		84.813M
350.68%		105.16M
23.99%		127.65M
21.39%		129.13M
1.16%		135.2M
4.70%
Operating Margin
VRCA operating margin by date.VRCA operating margin by date.
-1,233.84%-870.16%-33.56%-99.35%-22.26%21.15%49.08%53.01%55.56%53.08%53.14%
EPS
YoY % growth
VRCA eps by date.VRCA eps by date.
-14.60
-84.81%		-15.40
-5.48%		-1.47
90.45%		-1.37
6.65%		-0.43
68.78%		0.35
182.14%		3.47
885.51%		3.77
8.82%		3.88
2.70%		3.72
-3.95%		3.57
-4.11%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.46
54.47%		-0.40
-2,078.80%		-0.36
-1,100.20%		-0.33
29.12%
Revenue
Q2Q % growth		4.61M
34.72%		6.12M
-51.82%		7.048M
-50.86%		7.936M
55.85%
EBITDA
Q2Q % growth		N/AN/AN/AN/A
EBIT
Q2Q % growth		-6.719M
17.35%		-6.12M
-505.30%		-4.437M
-372.71%		-5.585M
19.60%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

VRCA Yearly Revenue VS EstimatesVRCA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 50M 100M 150M 200M 250M
VRCA Yearly EPS VS EstimatesVRCA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -5 -10 -15

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
30.83%
EPS Next 5 Year
35.50%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
35.48%
Revenue Next 5 Year
40.85%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

VERRICA PHARMACEUTICALS INC / VRCA Forecast FAQ

What is the average price target for VERRICA PHARMACEUTICALS INC (VRCA) stock?

11 analysts have analysed VRCA and the average price target is 16.83 USD. This implies a price increase of 163.79% is expected in the next year compared to the current price of 6.38.

When does VERRICA PHARMACEUTICALS INC (VRCA) report earnings?

VERRICA PHARMACEUTICALS INC (VRCA) will report earnings on 2026-05-12.

What are the consensus estimates for VRCA stock next earnings?

The consensus EPS estimate for the next earnings of VERRICA PHARMACEUTICALS INC (VRCA) is -0.46 USD and the consensus revenue estimate is 4.61M USD.

What is the number of analysts for VRCA stock?

The number of analysts covering VERRICA PHARMACEUTICALS INC (VRCA) is 11.